Episode 702 • • 1:16:21 - 1:20:01
702: Toddler Wage Gap
FDA Biosimilar Approval, Biotech Drug Pricing
The FDA has approved the first "biosimilar" drug, a low-cost version of the biotech drug Neupogen used for cancer patients. Unlike traditional generics, biosimilars are derived from living organisms; the discussion notes that the lack of transparent pricing for these drugs allows biotech firms to maintain high costs, exemplified by a recent $21 billion company buyout.